|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 3.100 USD | +2.65% |
|
-2.82% | -75.80% |
| 08-14 | Cerenome, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-02 | Plus Therapeutics, Inc. will Change its Name to Cerenome | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CERENOME, INC. | Other Biotechnology & Medical Research | +2.65% | +3.33% | -75.80% | -74.94% | -99.56% | 22.92M |  |  | |
- Stock Market
- Stocks
- CNSY Stock
- Charts Cerenome, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
